AllianceBernstein’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$265K Sell
12,130
-3,300
-21% -$104K ﹤0.01% 2936
2025
Q4
$337K Buy
15,430
+2,200
+17% +$45.7K ﹤0.01% 2855
2025
Q3
$284K Buy
13,230
+1,900
+17% +$42.6K ﹤0.01% 2961
2025
Q2
$291K Buy
11,330
+1,600
+16% +$46.8K ﹤0.01% 2928
2025
Q1
$356K Sell
9,730
-1,400
-13% -$48.2K ﹤0.01% 2694
2024
Q4
$341K Hold
11,130
﹤0.01% 2807
2024
Q3
$419K Hold
11,130
﹤0.01% 2752
2024
Q2
$441K Hold
11,130
﹤0.01% 2733
2024
Q1
$374K Hold
11,130
﹤0.01% 2717
2023
Q4
$371K Sell
11,130
-1,690
-13% -$54.5K ﹤0.01% 2753
2023
Q3
$402K Hold
12,820
﹤0.01% 2685
2023
Q2
$406K Buy
12,820
+1,420
+12% +$45.9K ﹤0.01% 2742
2023
Q1
$377K Hold
11,400
﹤0.01% 2684
2022
Q4
$367K Buy
11,400
+2,900
+34% +$98.7K ﹤0.01% 2787
2022
Q3
$304K Buy
8,500
+600
+8% +$24.9K ﹤0.01% 2860
2022
Q2
$324K Buy
7,900
+2,600
+49% +$126K ﹤0.01% 2847
2022
Q1
$307K Sell
5,300
-800
-13% -$43.8K ﹤0.01% 2864
2021
Q4
$358K Hold
6,100
﹤0.01% 2886
2021
Q3
$370K Sell
6,100
-700
-10% -$41K ﹤0.01% 2880
2021
Q2
$408K Sell
6,800
-61,884
-90% -$3.1M ﹤0.01% 2902
2021
Q1
$3.24M Buy
68,684
+17,540
+34% +$722K ﹤0.01% 1816
2020
Q4
$1.92M Sell
51,144
-41,567
-45% -$1.37M ﹤0.01% 2003
2020
Q3
$3.03M Sell
92,711
-52,751
-36% -$2.23M ﹤0.01% 1619
2020
Q2
$6.59M Buy
145,462
+72,192
+99% +$3.69M ﹤0.01% 1185
2020
Q1
$3.35M Sell
73,270
-8,046
-10% -$364K ﹤0.01% 1379
2019
Q4
$3.51M Buy
81,316
+30,623
+60% +$1.25M ﹤0.01% 1634
2019
Q3
$1.83M Buy
50,693
+40,593
+402% +$1.71M ﹤0.01% 1973
2019
Q2
$475K Sell
10,100
-300
-3% -$12.7K ﹤0.01% 2625
2019
Q1
$366K Hold
10,400
﹤0.01% 2666
2018
Q4
$389K Buy
10,400
+700
+7% +$27.4K ﹤0.01% 2594
2018
Q3
$329K Buy
9,700
+800
+9% +$23.4K ﹤0.01% 2800
2018
Q2
$222K Buy
8,900
+1,600
+22% +$44.6K ﹤0.01% 2934
2018
Q1
$218K Buy
7,300
+800
+12% +$26.8K ﹤0.01% 2818
2017
Q4
$209K Buy
+6,500
New +$209K ﹤0.01% 2851

Other funds holding ATEX

AllianceBernstein's ATEX Position: Q1 2026 in Review

AllianceBernstein reduced its Anterix (ATEX) stake by 21% in Q1 2026, selling an estimated $104K and leaving 12,130 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #2936.

AllianceBernstein first reported a position in ATEX in Q4 2017 and has held it in 34 quarters since. The position peaked at $6.59M in Q2 2020. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • AllianceBernstein held 12,130 shares of Anterix worth $265K as of Q1 2026.
  • AllianceBernstein sold 3,300 Anterix shares in Q1 2026, an estimated $104K.
  • Anterix made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2936 holding.
  • AllianceBernstein first reported a position in Anterix in Q4 2017 and has held it in 34 quarters since.
  • AllianceBernstein's Anterix position peaked at $6.59M in Q2 2020.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.